Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 77

Sort by

Sort Order Select

Journal Articles

CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma

Jia Li, Zhi-Qiang Hu, Song-Yang Yu, Li Mao, Zheng-Jun Zhou, Peng-Cheng Wang, Yu Gong, Sheng Su, Jian Zhou, Jia Fan, Shao-Lai Zhou, Xiao-Wu Huang

Cancer Res (2022) 82 (6): 1055–1069.

https://doi.org/10.1158/0008-5472.CAN-21-1259

Published: 15 March 2022

View articletitled, CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP

David J. de Gorter, Alexandre Deshiere, Martijn van Rosmalen, Christian Wohn, Berina Eppink, Tristan Gallenne, Rinse Klooster, Li Mao, Wenxin Xu, Liang Deng, Qingyu Shu, Wei Liu, John de Kruif, Mario Di Matteo, Massimiliano Mazzone, Mark Throsby, Cecile A. Geuijen

Cancer Res (2021) 81 (13_Supplement): 952.

https://doi.org/10.1158/1538-7445.AM2021-952

Published: 01 July 2021

View articletitled, Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP

Journal Articles

Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Cancer Res (2020) 80 (16_Supplement): 2997.

https://doi.org/10.1158/1538-7445.AM2020-2997

Published: 15 August 2020

View articletitled, Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Journal Articles

Abstract 579: Ensartinib (X-396), a novel ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation and expansion study

Hongyun Zhao, Yuxiang Ma, Yang Zhang, Shaodong Hong, Wenfeng Fang, Yunpeng Yang, Jianjin Huang, Jing Zhao, Yan Huang, Lieming Ding, Li Mao, Giovanni Selvaggi, Li Zhang

Cancer Res (2020) 80 (16_Supplement): 579.

https://doi.org/10.1158/1538-7445.AM2020-579

Published: 15 August 2020

View articletitled, Abstract 579: Ensartinib (X-396), a novel ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation and expansion study

Journal Articles

Abstract LB-186: MET receptor tyrosine kinase is a potential novel target for prevention of oral cancer.

Pierre Saintigny, Mark W. Lingen, William Nassib William, Wenhua Lang, Lei Feng, J. Jack Lee, Edward S. Kim, Adel K. El-Naggar, Vassiliki Papadimitrakopoulou, Scott M. Lippman, Li Mao, Waun Ki Hong

Cancer Res (2013) 73 (8_Supplement): LB-186.

https://doi.org/10.1158/1538-7445.AM2013-LB-186

Published: 15 April 2013

View articletitled, Abstract LB-186: MET receptor tyrosine kinase is a potential novel target for prevention of oral cancer.

Journal Articles

Abstract 4819: Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)

Cancer Res (2012) 72 (8_Supplement): 4819.

https://doi.org/10.1158/1538-7445.AM2012-4819

Published: 15 April 2012

View articletitled, Abstract 4819: Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)

Journal Articles

Abstract 3674: Gene expression analysis of field of cancerization in early stage NSCLC patients towards development of biomarkers for personalized prevention

Humam Kadara, Pierre Saintigny, Youhong Fan, Chi-Wan Chow, ZuoMing Chu, Wenhua Lang, Carmen Behrens, Kathryn Gold, Diane Liu, J. Jack Lee, Li Mao, Edward S. Kim, Waun K. Hong, Ignacio I. Wistuba

Cancer Res (2011) 71 (8_Supplement): 3674.

https://doi.org/10.1158/1538-7445.AM2011-3674

Published: 15 April 2011

View articletitled, Abstract 3674: Gene expression analysis of field of cancerization in early stage NSCLC patients towards development of biomarkers for personalized prevention

Journal Articles

Abstract 4109: A 5-gene signature (sig) predicts clinical benefit from erlotinib in non-small cell lung cancer (NSCLC) patients (pts) harboring wild-type (wt) EGFR & KRAS

Cancer Res (2011) 71 (8_Supplement): 4109.

https://doi.org/10.1158/1538-7445.AM2011-4109

Published: 15 April 2011

View articletitled, Abstract 4109: A 5-gene signature (sig) predicts clinical benefit from erlotinib in non-small cell lung cancer (NSCLC) patients (pts) harboring wild-type (wt) EGFR & KRAS

Journal Articles

Abstract LB-88: Gene expression signatures predictive of clinical outcome and tumor mutations in refractory NSCLC patients (pts) in the BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination)

Cancer Res (2011) 71 (8_Supplement): LB-88.

https://doi.org/10.1158/1538-7445.AM2011-LB-88

Published: 15 April 2011

View articletitled, Abstract LB-88: Gene expression signatures predictive of clinical outcome and tumor mutations in refractory NSCLC patients (pts) in the BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination)

Journal Articles

Abstract 1981: MYC downregulation and chemoresistance in non-small cell lung cancer (NSCLC): Evidence from the Biomarker-Based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) program

Pierre Saintigny, Lauren A. Byers, Li Zhang, John S. Yordy, Xi M. Tang, Luc Girard, Wenhua Lang, You H. Fan, Lin Ji, Jack J. Lee, Edward S. Kim, Waun K. Hong, Scott M. Lippman, Roy S. Herbst, John Minna, Ignacio I. Wistuba, John V. Heymach, Li Mao

Cancer Res (2010) 70 (8_Supplement): 1981.

https://doi.org/10.1158/1538-7445.AM10-1981

Published: 15 April 2010

View articletitled, Abstract 1981: MYC downregulation and chemoresistance in non-small cell lung cancer (NSCLC): Evidence from the Biomarker-Based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) program

Journal Articles

Abstract #744: Feasibility and adequacy of molecular biomarkers analysis from core needle biopsies in lung cancer: toward personalized targeted therapy development

Ximing Tang, Edward Kim, Christine Alden, Sanjay Gupta, Anne Tsao, George Blumenschein, Suyu Liu, John Heymach, David Stewart, Li Mao, Marhsal Hicks, Scott Lippman, J. Jack Lee, Roy Herbst, Waun Hong, Ignacio Wistuba

Cancer Res (2009) 69 (9_Supplement): 744.

Published: 01 May 2009

View articletitled, Abstract #744: Feasibility and adequacy of molecular biomarkers analysis from core needle biopsies in lung cancer: toward personalized targeted therapy development

Journal Articles

Abstract #1320: Loss of DNMT3B catalytic domain is a common event in development of non-small cell lung cancer

Manisha Bhutani, Ashutosh Pathak, Hening Ren, Li Mao

Cancer Res (2009) 69 (9_Supplement): 1320.

Published: 01 May 2009

View articletitled, Abstract #1320: Loss of DNMT3B catalytic domain is a common event in development of non-small cell lung cancer

Journal Articles

Abstract 1599: Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

Manisha Bhutani, Ashutosh K Pathak, You Hong Fan, Diane D Liu, J. Jack Lee, Hongli Tang, Jonathan M Kurie, Rodolfo C Morice, Edward S Kim, Waun K Hong, Li Mao

Cancer Res (2008) 68 (9_Supplement): 1599.

https://doi.org/10.1158/1538-7445.AM2008-1599

Published: 15 May 2008

View articletitled, Abstract 1599: Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

Journal Articles

Effect of celecoxib on expression of MAGE tumor antigens in bronchial epithelium of chronic smokers

Ashutosh Pathak, Manisha Bhutani, Hongli Tang, You Hong Fan, Diane Liu, Jack Lee, Jonathan Kurie, Rodolfo Morice, Waun Hong, Li Mao

Cancer Res (2008) 68 (9_Supplement): 496.

Published: 01 May 2008

View articletitled, Effect of celecoxib on expression of MAGE tumor antigens in bronchial epithelium of chronic smokers

Journal Articles

Resistance to platin-based neoadjuvant chemotherapy for head and neck cancer is mediated by bNIP3

Ying Zhang, Dana Bui, Li Mao, Francois Janot, Kevin Coombes, Stephane Temam, Floyd Holsinger

Cancer Res (2008) 68 (9_Supplement): 3631.

Published: 01 May 2008

View articletitled, Resistance to platin-based neoadjuvant chemotherapy for head and neck cancer is mediated by bNIP3

Journal Articles

Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

Manisha Bhutani, Ashutosh Pathak, You Hong Fan, Diane Liu, J. Jack Lee, Hongli Tang, Jonathan Kurie, Rodolfo Morice, Edward Kim, Waun Hong, Li Mao

Cancer Res (2008) 68 (9_Supplement): 1599.

Published: 01 May 2008

View articletitled, Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

Journal Articles

microRNA (miRNA) species differentially expressed between immortalized normal bronchial epithelial cells and non-small cell lung cancer (NSCLC) cells

Pierre Saintigny, Hening Ren, Xiaochuan Zou, Li Mao

Cancer Res (2008) 68 (9_Supplement): 5046.

Published: 01 May 2008

View articletitled, microRNA (miRNA) species differentially expressed between immortalized normal bronchial epithelial cells and non-small cell lung cancer (NSCLC) cells

Journal Articles

ΔDNMT3B Variants Regulate DNA Methylation in a Promoter-Specific Manner

Jie Wang, Manisha Bhutani, Ashutosh K. Pathak, Wenhua Lang, Hening Ren, Jaroslav Jelinek, Rong He, Lanlan Shen, Jean-Pierre Issa, Li Mao

Cancer Res (2007) 67 (22): 10647–10652.

https://doi.org/10.1158/0008-5472.CAN-07-1337

Published: 15 November 2007

View articletitled, ΔDNMT3B Variants Regulate DNA Methylation in a Promoter-Specific Manner

Includes: Supplementary data

Journal Articles

Podoplanin expression is a novel marker of oral cancer risk in patients with oral premalignancy

Li Mao, Hidetoshi Kawaguchi, Hening Ren, Zouming Chu, You-Hong Fan, Lei Feng, Jack Lee, Adel El-Naggar, Edward Kim, Waun Ki Hong, Scott Lippman

Cancer Res (2007) 67 (9_Supplement): 1677.

Published: 01 May 2007

View articletitled, Podoplanin expression is a novel marker of oral cancer risk in patients with oral premalignancy

Journal Articles

Methylation status in buccal cells as a potential surrogate strategy for lung cancer risk assessment in chronic smokers

Manisha Bhutani, Ashutosh Pathak, Diane Liu, J.Jack Lee, Hongli Tang, You-Hong Fan, Jonathan Kurie, Rodolfo Morice, Waun Hong, Li Mao

Cancer Res (2007) 67 (9_Supplement): 1117.

Published: 01 May 2007

View articletitled, Methylation status in buccal cells as a potential surrogate strategy for lung cancer risk assessment in chronic smokers

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma

Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP

Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Abstract 579: Ensartinib (X-396), a novel ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation and expansion study

Abstract LB-186: MET receptor tyrosine kinase is a potential novel target for prevention of oral cancer.

Abstract 4819: Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)

Abstract 3674: Gene expression analysis of field of cancerization in early stage NSCLC patients towards development of biomarkers for personalized prevention

Abstract 4109: A 5-gene signature (sig) predicts clinical benefit from erlotinib in non-small cell lung cancer (NSCLC) patients (pts) harboring wild-type (wt) EGFR & KRAS

Abstract LB-88: Gene expression signatures predictive of clinical outcome and tumor mutations in refractory NSCLC patients (pts) in the BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination)

Abstract 1981: MYC downregulation and chemoresistance in non-small cell lung cancer (NSCLC): Evidence from the Biomarker-Based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) program

Abstract #744: Feasibility and adequacy of molecular biomarkers analysis from core needle biopsies in lung cancer: toward personalized targeted therapy development

Abstract #1320: Loss of DNMT3B catalytic domain is a common event in development of non-small cell lung cancer

Abstract 1599: Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

Effect of celecoxib on expression of MAGE tumor antigens in bronchial epithelium of chronic smokers

Resistance to platin-based neoadjuvant chemotherapy for head and neck cancer is mediated by bNIP3

Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in lungs

microRNA (miRNA) species differentially expressed between immortalized normal bronchial epithelial cells and non-small cell lung cancer (NSCLC) cells

ΔDNMT3B Variants Regulate DNA Methylation in a Promoter-Specific Manner

Podoplanin expression is a novel marker of oral cancer risk in patients with oral premalignancy

Methylation status in buccal cells as a potential surrogate strategy for lung cancer risk assessment in chronic smokers

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only